Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Absenger · SciRah

Researcher profile · Semantic Scholar

G. Absenger

Share profile

G. Absenger — researcher profile on SciRah

h-index: 21
Works: 65
Citations: 2,068

Most-cited papers

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
M. Stotz, M. Pichler, G. Absenger, J. Szkandera +5 more
2013British Journal of Cancer317 citations Open access
Semantic Scholar
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
G. Absenger, J. Szkandera, M. Pichler, M. Stotz +6 more
2013British Journal of Cancer234 citations Open access
Semantic Scholar
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
J. Szkandera, A. Gerger, B. Liegl-Atzwanger, G. Absenger +7 more
2014International Journal of Cancer173 citations
Semantic Scholar
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
J. Szkandera, G. Absenger, B. Liegl-Atzwanger, M. Pichler +7 more
2013British Journal of Cancer151 citations Open access
Semantic Scholar
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
J. Szkandera, M. Pichler, G. Absenger, M. Stotz +8 more
2014American Journal of Surgery110 citations
Semantic Scholar
External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
J. Szkandera, M. Stotz, F. Eisner, G. Absenger +10 more
2013PLoS ONE105 citations Open access
Semantic Scholar
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
J. Riedl, D. Barth, W. Brueckl, G. Zeitler +15 more
2020Cancers100 citations Open access
Semantic Scholar
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
J. Szkandera, A. Gerger, B. Liegl-Atzwanger, G. Absenger +7 more
2013British Journal of Cancer93 citations Open access
Semantic Scholar
Pharmacogenetic angiogenesis profiling for first-line bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
A. Gerger, A. El-Khoueiry, Wu Zhang, Dong-Yun Yang +11 more
2011Clinical Cancer Research88 citations Open access
Semantic Scholar
Immune Aging and Immunotherapy in Cancer
M. Kaiser, M. D. Semeraro, M. Herrmann, G. Absenger +2 more
2021International Journal of Molecular Sciences67 citations Open access
Semantic Scholar
Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
G. Absenger, J. Szkandera, M. Stotz, Ulrich Postlmayr +6 more
2013Anticancer Research67 citations
Semantic Scholar
Cell‐Free Plasma DNA‐Guided Treatment With Osimertinib in Patients With Advanced EGFR‐Mutated NSCLC
A. Buder, Maximilian J. Hochmair, S. Schwab, T. Bundalo +11 more
2018Journal of Thoracic Oncology61 citations Open access
Semantic Scholar
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
O. Illini, M. Hochmair, H. Fabikan, C. Weinlinger +29 more
2021Therapeutic Advances in Medical Oncology41 citations Open access
Semantic Scholar
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
D. Barth, S. Stanzer, J. Spiegelberg, T. Bauernhofer +14 more
2022Frontiers in Immunology36 citations Open access
Semantic Scholar
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases
David B. Chapel, Jefree J. Schulte, G. Absenger, R. Attanoos +16 more
2020Modern Pathology36 citations Open access
Semantic Scholar
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
M. Hochmair, H. Fabikan, O. Illini, C. Weinlinger +13 more
2020Pharmaceuticals32 citations Open access
Semantic Scholar
Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
L. Brčić, S. Stanzer, D. Krenbek, U. Gruber-Moesenbacher +9 more
2018Virchows Archiv28 citations Open access
Semantic Scholar
Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
D. Barth, S. Stanzer, J. Spiegelberg, T. Bauernhofer +14 more
2022Cancer Medicine26 citations Open access
Semantic Scholar
The elevated pre‐operative plasma fibrinogen level is an independent negative prognostic factor for cancer‐specific, disease‐free and overall survival in soft‐tissue sarcoma patients
J. Szkandera, M. Pichler, B. Liegl-Atzwanger, G. Absenger +7 more
2014Journal of Surgical Oncology24 citations
Semantic Scholar
Reflex testing in non-small cell lung carcinoma using DNA- and RNA-based next-generation sequencing—a single-center experience
M. Zacharias, G. Absenger, K. Kashofer, R. Wurm +7 more
2021Translational Lung Cancer Research21 citations Open access
Semantic Scholar
A Functional Germline Variant in GLI1 Implicates Hedgehog Signaling in Clinical Outcome of Stage II and III Colon Carcinoma Patients
J. Szkandera, M. Pichler, G. Absenger, M. Stotz +8 more
2014Clinical Cancer Research21 citations Open access
Semantic Scholar
Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series
M. Stotz, F. Eisner, J. Szkandera, G. Absenger +5 more
2013Journal of Clinical Pathology21 citations
Semantic Scholar
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC
Nikolaus John, Verena Schlintl, T. Sassmann, J. Lindenmann +10 more
2024Journal for ImmunoTherapy of Cancer20 citations Open access
Semantic Scholar
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy
G. Absenger, L. Benhaim, J. Szkandera, Wu Zhang +8 more
2013The Pharmacogenomics Journal20 citations
Semantic Scholar
ASCO update: lung cancer
G. Absenger, J. Terzic, Angelika Bezan
2017memo - Magazine of European Medical Oncology19 citations Open access
Semantic Scholar
Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
J. Szkandera, G. Absenger, N. Dandachi, P. Regitnig +5 more
2012Zeitschrift für Induktive Abstammungs- und Vererbungslehre15 citations
Semantic Scholar
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
N. Dandachi, V. Tiran, J. Lindenmann, L. Brčić +7 more
2017Lung Cancer14 citations
Semantic Scholar
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early‐stage breast cancer
G. Absenger, J. Szkandera, M. Stotz, M. Pichler +6 more
2013Molecular Carcinogenesis13 citations
Semantic Scholar
A common gene variant in PLS3 predicts colon cancer recurrence in women
J. Szkandera, T. Winder, M. Stotz, Melanie Weissmueller +6 more
2013Tumor Biology13 citations
Semantic Scholar
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence
J. Szkandera, G. Absenger, M. Pichler, M. Stotz +4 more
2013Journal of Cancer Research and Clinical Oncology13 citations Open access
Semantic Scholar
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
J. Szkandera, G. Absenger, B. Liegl-Atzwanger, M. Pichler +7 more
2013Cancer Epidemiology11 citations
Semantic Scholar
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types
Irina Robinson, M. Hochmair, M. Schmidinger, G. Absenger +11 more
2023Cancers9 citations Open access
Semantic Scholar
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines
F. Moik, G. Absenger, R. Wurm, M. Hochmair +1 more
2025Cancers8 citations Open access
Semantic Scholar
Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
O. Illini, H. Fabikan, M. Hochmair, C. Weinlinger +7 more
2022Journal of Clinical Medicine8 citations Open access
Semantic Scholar
The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers
H. Popper, U. Gruber-Mösenbacher, G. Pall, L. Müllauer +17 more
2020memo - Magazine of European Medical Oncology8 citations
Semantic Scholar
Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology
M. Zacharias, S. Konjić, Nikolaus Kratochwill, G. Absenger +8 more
2024Cancers7 citations Open access
Semantic Scholar
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer
S. Geiger-Gritsch, H. Olschewski, F. Kocher, R. Wurm +9 more
2021Wiener Klinische Wochenschrift6 citations
Semantic Scholar
External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
J. Riedl, D. Barth, V. Foris, F. Posch +7 more
2019Annals of Oncology6 citations Open access
Semantic Scholar
EGFR T790M resistance mutation in NSCLC: Real-life data of patients treated with osimertinib.
Maximilian J. Hochmair, S. Holzer, M. Filipits, A. Mohn-Staudner +10 more
20166 citations
Semantic Scholar
The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.
J. Szkandera, G. Absenger, M. Stotz, Melanie Weissmueller +6 more
2012Anticancer Research5 citations
Semantic Scholar
Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
H. Popper, U. Gruber-Mösenbacher, G. Hutarew, Maximilian J. Hochmair +15 more
2016memo - Magazine of European Medical Oncology4 citations
Semantic Scholar
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
G. Hofmann, U. Langsenlehner, T. Langsenlehner, M. Glehr +7 more
2011Anticancer Research4 citations
Semantic Scholar
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer
G. Absenger, A. Pircher
2021memo - Magazine of European Medical Oncology2 citations Open access
Semantic Scholar
113P C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study
F. Posch, D. Barth, W. Brueckl, G. Zeitler +15 more
2020Annals of Oncology2 citations Open access
Semantic Scholar
P3.02b-101 EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib
Maximilian J. Hochmair, S. Holzer, M. Filipits, A. Mohn-Staudner +13 more
20172 citations Open access
Semantic Scholar
Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids
A. Sexton-Oates, É. Mathian, N. Candeli, Y. Lim +71 more
2026Molecular Cancer1 citations Open access
Semantic Scholar
117P BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
Ivan Ochsenius Robinson, M. Schmidinger, M. Hochmair, L. Ay +10 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
55P Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)
Ivan Ochsenius Robinson, M. Hochmair, L. Ay, G. Absenger +6 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
Unresectable pleural mesothelioma—hope or still an unmet medical need?
G. Absenger, A. Terbuch
2021memo - Magazine of European Medical Oncology1 citations Open access
Semantic Scholar
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance
G. Absenger
2019memo - Magazine of European Medical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Gerger×26
Invite
A. Gerger — researcher profile on SciRah
M. Stotz×21
Invite
M. Stotz — researcher profile on SciRah
M. Pichler×21
Invite
M. Pichler — researcher profile on SciRah
J. Szkandera×21
Invite
J. Szkandera — researcher profile on SciRah

×17

Invite

H. Samonigg — researcher profile on SciRah

Invite

W. Renner — researcher profile on SciRah

T. Stojaković×8

Invite

T. Stojaković — researcher profile on SciRah

Invite

A. Terbuch — researcher profile on SciRah

Invite

U. Setinek — researcher profile on SciRah

Invite

L. Brčić — researcher profile on SciRah

R. Schaberl-Moser×5

Invite

R. Schaberl-Moser — researcher profile on SciRah

Melanie Weissmueller×5

Invite

Melanie Weissmueller — researcher profile on SciRah